Trial NCT03075527

View at ClinicalTrials.gov 
Org. Study IDs: 16-549

Last trial update was posted on 2024-01-25

MeSH Interventions

Durvalumab Tremelimumab

MeSH Conditions

Mesothelioma Mesothelioma, Malignant

Other Conditions


Stopping Reasons

Criteria not met for second stage at time of interim analysis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID